OVID THERAPEUTICS INC.

Transcripts Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-09 pm EDT			5-day change	1st Jan Change
0.8299 ^USD	-0.71%		+7.31%	-74.23%

Jul. 09	Immunic Names President/COO, Chief Development Officer	MT
Jul. 09	Immunic Names Jason Tardio as COO, Werner Gladdines as Chief Development Officer	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Ovid Therapeutics Inc. - Special Call	23-10-02
Transcript : Ovid Therapeutics Inc. - Shareholder/Analyst Call	21-06-10
Transcript : Ovid Therapeutics Inc. Presents at RBC Capital Markets 2021 Global Healthcare Conference, May-19-2021 09:10 AM	21-05-19
Transcript : Ovid Therapeutics Inc. - Special Call	21-03-03
Transcript : Ovid Therapeutics Inc. - Special Call	20-10-22
Transcript : Ovid Therapeutics Inc. - Special Call	20-08-25
Transcript : Ovid Therapeutics Inc. - Special Call	20-07-13
Transcript : Ovid Therapeutics Inc. - Special Call	20-06-17
Transcript : Ovid Therapeutics Inc. - Shareholder/Analyst Call	20-06-04
Transcript : Ovid Therapeutics Inc. - Special Call	19-09-23
Transcript : Ovid Therapeutics Inc. - Special Call	19-06-27
Transcript : Ovid Therapeutics Inc. - Special Call	18-12-17
Transcript : Ovid Therapeutics Inc. - Special Call	18-10-25
Transcript : Ovid Therapeutics Inc. - Special Call	18-08-06
Transcript : Ovid Therapeutics Inc. Presents at 43rd Annual Deutsche Bank Healthcare Conference, May-09-2018 10:40 AM	18-05-09
Transcript : Ovid Therapeutics Inc., Q4 2017 Earnings Call, Mar 29, 2018	18-03-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer